BMS-986460
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
February 05, 2026
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=140 | Recruiting | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Recruiting
Enrollment open • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
January 21, 2026
CA125-1018: A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants
(clinicaltrials.gov)
- P1 | N=85 | Completed | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Completed | N=56 ➔ 85
Enrollment change • Trial completion
October 04, 2025
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=140 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | N=90 ➔ 140 | Trial completion date: Jan 2029 ➔ Jul 2031 | Trial primary completion date: Jan 2027 ➔ Aug 2029
Enrollment change • Trial completion date • Trial primary completion date • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
August 01, 2025
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=90 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting
Enrollment closed • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
April 15, 2025
CA125-1018: A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants
(clinicaltrials.gov)
- P1 | N=56 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting
Enrollment open
March 17, 2025
A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants
(clinicaltrials.gov)
- P1 | N=56 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
New P1 trial
October 11, 2023
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
October 05, 2023
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=90 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
Metastases • New P1 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 8
Of
8
Go to page
1